Celldex Therapeutics | CLDX - Assets

Stock Price
29.51
Daily Change
4.67 18.78%
Monthly
11.05%
Yearly
41.85%
Q1 Forecast
22.31

Celldex Therapeutics reported $648.44M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Agenus USD 233.89M 48.67M Sep/2025
Amgen USD 90.59B 445M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Celldex Therapeutics USD 648.44M 43.97M Sep/2025
Glaxosmithkline GBP 82.45B 23.19B Sep/2025
Nektar Therapeutics USD 301.35M 93.81M Sep/2025
Northwest Biotherapeutics USD 30.61M 1.06M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Rigel Pharmaceuticals USD 242.53M 35.8M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025